CN Patent

CN114796496B — 交感神经活化抑制剂和/或α1-肾上腺素能受体抑制剂在制备治疗干眼症的药物中的应用

Assigned to Institute Of Ophthalmology Affiliated To Shandong First Medical University Shandong Institute Of Ophthalmology And Qingdao Eye Hospital Affiliated To Shandong First Medical University · Expires 2023-06-23 · 3y expired

What this patent protects

本发明涉及交感神经活化抑制剂和/或α1‑肾上腺素能受体抑制剂在制备治疗干眼症的药物中的应用，属于干眼症治疗药物技术领域。本发明提供了交感神经活化抑制剂和/或α1‑肾上腺素能受体抑制剂在制备治疗或缓解干眼症的药物中的应用，本发明所述应用制备得到的药物能够拮抗α1‑肾上腺素能受体(包括α1a‑肾上腺素能受体)或抑制交感神经活化，能缓解、治疗干眼症状。

USPTO Abstract

本发明涉及交感神经活化抑制剂和/或α1‑肾上腺素能受体抑制剂在制备治疗干眼症的药物中的应用，属于干眼症治疗药物技术领域。本发明提供了交感神经活化抑制剂和/或α1‑肾上腺素能受体抑制剂在制备治疗或缓解干眼症的药物中的应用，本发明所述应用制备得到的药物能够拮抗α1‑肾上腺素能受体(包括α1a‑肾上腺素能受体)或抑制交感神经活化，能缓解、治疗干眼症状。

Drugs covered by this patent

Patent Metadata

Patent number
CN114796496B
Jurisdiction
CN
Classification
—
Expires
2023-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Institute Of Ophthalmology Affiliated To Shandong First Medical University Shandong Institute Of Ophthalmology And Qingdao Eye Hospital Affiliated To Shandong First Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.